Medical bill for lung cancer patients goes down

Korea’s National Health Insurance has expanded its coverage to Eli Lilly’s chemotherapy drug Alimta (pemetrexed) as the first line drug for locally advanced or metastatic, nonsquamous, non-small cell lung cancer, according to Lilly Korea.

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Subtypes of NSCLC include adenocarcinoma, squamous cell carcinoma, and large cel...